News related to Prednisone and/or conditions it is approved for
Cabazitaxel Increased Survival For Patients With Advanced Hormone-Refractory Prostate Cancer Source: Prostate / Prostate Cancer News From Medical News Today [2010.03.04] Sanofi-aventis (EURONEXT: SAN and NYSE: SNY) announced results from a Phase 3 trial which demonstrated cabazitaxel, an investigational compound, plus prednisone/prednisolone significantly improved overall survival and progression-free survival in patients with metastatic (advanced) hormone-refractory prostate cancer whose disease progressed following treatment with docetaxel-based chemotherapy...